bifeprunox

Known as: 1-(2-Oxo-benzoxazolin-7-yl)-4-(3-biphenyl)methylpiperazinemesylate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
0520052016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Species differences in physiology and unique active human metabolites contribute to the limited predictive value of preclinical… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The atypical antipsychotic bifeprunox is a partial dopamine D(2) and 5-HT(1A) receptor agonist. Using in-vivo… (More)
Is this relevant?
2009
2009
Bifeprunox and aripiprazole are two novel antipsychotics presenting partial agonistic activity for the D(2) and D(3) dopamine (DA… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Because long-term antipsychotics elicit behavioral dopamine supersensitivity, the present study examined whether 7-9 days… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Bifeprunox is a partial dopamine agonist with a unique receptor-binding profile and potential antipsychotic properties. The… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2008
2008
Several novel antipsychotics activate serotonin 5-HT1A receptors as well as antagonising dopamine D2/3 receptors. Such a… (More)
Is this relevant?
2007
2007
Aripiprazole is the first dopamine D(2) receptor partial agonist approved for use in schizophrenia and bipolar disorder. Other… (More)
Is this relevant?
2007
2007
Most second-generation, atypical, dopamine (DA) D2/5-HT2 blocking antipsychotics still induce extrapyramidal side effects (EPS… (More)
  • figure 1
  • table 1
  • table 3
Is this relevant?
2006
2006
Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade. We compared the… (More)
Is this relevant?
2005
2005
Several novel antipsychotics, such as aripiprazole, bifeprunox, SSR181507 [(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?